NRx Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $8 | $8 |
Gross Profit | -1 | -1 | 7 |
EBITDA | -7,047 | -6,297 | -4,405 |
EBIT | -7,048 | -6,298 | -4,448 |
Net Income | -7,897 | -6,528 | -4,332 |
Net Change In Cash | 0 | 8 | 8 |
Free Cash Flow | -3,505 | -3,671 | -3,188 |
Cash | 1,898 | 1,319 | 4,595 |
Basic Shares | 10,517 | 8,852 | 83,919 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5 | -4 | -2 | -907 |
EBITDA | -30,025 | -39,750 | -93,043 | -51,719 |
EBIT | -30,030 | -39,754 | -93,045 | -51,721 |
Net Income | -30,150 | -35,235 | -71,715 | -12,347 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | ||||
Free Cash Flow | -21,660 | -39,765 | -37,710 | -2,267 |
Cash | 4,595 | 20,054 | 27,605 | 1,859 |
Basic Shares | 7,576 | 65,766 | 46,917 | 34,270 |
Earnings Calls
| Quarter | EPS |
|---|---|
2021-06-30 | -$0.40 |
2021-03-31 | -$6.51 |
2020-12-31 | -$2.25 |
2020-06-30 | -$0.15 |
